Abstract
Importance The long-term impacts of early-life famine exposure on Type 2 Diabetes Mellitus (T2DM) have been widely documented across countries, but it remains less clear what is the critical time window and if there is a dose-response between famine intensity and risk of T2DM.
Objective To establish the relation between prenatal famine exposure and adult Type 2 diabetes mellitus (T2DM).
Design A national cross-sectional study.
Setting The man-made Ukrainian Holodomor famine of 1932-1933.
Participants A total number of 128,225 T2DM cases diagnosed at age 40 or over from the national diabetes register 2000-2008 in Ukraine. The population at risk includes 10,186,016 Soviet Ukraine births (excepting one oblast/province) between 1930-1938 classified by month and year and oblast of birth.
Exposure Births born in January-June 1934 from oblasts that experienced extreme, severe, or significant famine in 1932-1933. Famine intensity was measured based on the excess mortality during the famine.
Main Outcomes and Measures T2DM diagnosis was based on WHO (1999) criteria.
Results We observed in univariate analysis a 1.8-fold increase in T2DM (OR 1.80; 95% CI 1.74-1.85) among individuals born in the first half-year of 1934 in regions with extreme, severe, or significant famine. We observed no increase among individuals born in regions with no famine. In multivariate analysis across regions and adjusting for season of birth we observed a larger than 2-fold increase (OR 2.21; 95% CI 2.00-2.45). There was a dose-response by famine intensity, with ORs increasing from 1.94 to 2.39 across regions. The pattern was similar in men and women.
Conclusions and Relevance Births in the first half-year of 1934 were conceived at the height of the Ukraine famine in 1933. This relation for T2DM outcomes points to early gestation as a critical time window relating maternal nutrition in pregnancy to offspring health in later life. Further studies of biological mechanisms should focus on this time window for which changes in DNA methylation and later body size have also been observed.
Question What is the critical time window for early-life famine exposure on Type 2 Diabetes Mellitus (T2DM)? Is there any dose-response relationship between early-life famine exposure and T2DM?
Findings We found an increased risk of T2DM (Odds Ratio 2.21; 95% CI 2.00-2.45) among individuals born during the first half-year of 1934. A clear dose-response relationship was observed using excess mortality as a measure of famine intensity.
Meaning Early gestation is a critical time window relating maternal undernutrition in pregnancy to offspring health in later life.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding provided by the Ukraine State complex program Diabetes Mellitus, project number 0106U000844. LHL and OW received support from the Holodomor Research and Education Consortium in Canada. LHL received support from a NIDI-NIAS Fellowship of the Royal Netherlands Academy of Sciences and from grants R01 AG028593 (PI: Lumey) and R01 AG06687 (MPIs: Lumey and Belsky) National Institute of Aging, National Institutes of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The use of anonymized data was approved by the institutional review board of the Komisarenko Institute of Endocrinology and Metabolism, Kyiv, Ukraine, and the need for informed consent for the purpose of this study was waived.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.
